TP53 and neoplasm: We utilized a series of engineered human BJ cell lines12 to delineate the molecular basis for a131-mediated tumor cell-selectivity (Fig. 1f), and we found that inhibition of the p16-pRb, p53, and PP2A tumor suppressor pathways in various combinations did not significantly contribute to a131-induced cell death.